Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Özlem Türeci
Age : 53
Country of residence : Unknown
Linked companies : BioNTech SE

Biography of Özlem Türeci 
Özlem Türeci founded BioNTech SE and Ganymed Pharmaceuticals AG. Currently, she holds the position of Chairman for Ci3 Management UG, President at Association For Cancer Immunotherapy and Chief Medical Officer for BioNTech SE. In the past she occupied the position of Chief Executive & Medical Officer at Ganymed Pharmaceuticals AG. Dr. Türeci received an undergraduate degree from Universität des Saarlandes.


Current positions of Özlem Türeci 
Özlem Türeci : Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Özlem Türeci : Connections 


Latest news about Özlem Türeci 
09/18PRESS RELEASE : FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY(R) Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
DJ
09/10BIONTECH : in Process to Launch COVID-19 Vaccine for Children Under 12
MT
07/23PRESS RELEASE : Fighting Infectious Diseases on the African Continent
DJ
06/18PRESS RELEASE : BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
DJ
04/27PRESS RELEASE : MIG AG records 2020 as the most successful year in its company history and aims at further growth
DJ
02/18PRESS RELEASE : Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
DJ
2020PRESS RELEASE : Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
DJ
More news